Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women.
To determine prevalence and predictors of complementary and alternative medicine (CAM) use disclosure to health care providers and whether CAM use disclosure is associated with highly active antiretroviral therapy (HAART) adherence among HIV-infected women, we analyzed longitudinal data collected between October 1994 and March 2002 from HIV-infected CAM-using women enrolled in the Women's Interagency HIV Study. Repeated measures Poisson regression models were constructed to evaluate associations of selected predictors with CAM use disclosure and association between CAM use disclosure and HAART adherence. A total of 1,377 HIV-infected women reported CAM use during study follow-up and contributed a total of 4,689 CAM-using person visits. The overall prevalence of CAM use disclosure to health care providers was 36% across study visits. Women over 45 years old, with a college education, or with health insurance coverage were more likely to disclose their CAM use to health care providers, whereas women identified as non-Hispanic Black or other ethnicities were less likely to communicate their CAM usage. More health care provider visits, more CAM domains used, and higher health care satisfaction scores had significant relationships with increased levels of CAM use disclosure. Restricting analysis to use of herbal or nonherbal medications only, similar results were obtained. Compared to other CAM domains, mind-body practice had the lowest prevalence of CAM use disclosure. Additionally, CAM use disclosure was significantly associated with higher HAART adherence. From this study, we showed that a high percentage of HIV-infected women did not discuss their CAM use with health care providers. Interventions targeted towards both physicians and patients may enhance communication of CAM use, avoid potential adverse events and drug interactions, and enhance HAART adherence.
Liu
Chenglong
C
Department of Medicine, Georgetown University, Washington, D.C 20007, USA. cl278@georgetown.edu
Yang
Yang
Y
Gange
Stephen J
SJ
Weber
Kathleen
K
Sharp
Gerald B
GB
Wilson
Tracey E
TE
Levine
Alexandra
A
Robison
Esther
E
Goparaju
Lakshmi
L
Gandhi
Monica
M
Ganhdi
Monica
M
Merenstein
Dan
D
D023241:Antiretroviral Therapy, Highly Active / Q000706:statistics & numerical data*; D001294:Attitude to Health; D000529:Complementary Therapies / Q000706:statistics & numerical data*; D030881:Disclosure; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000523:psychology / Q000628:therapy*; D015497:HIV-1; D006282:Health Personnel; D006801:Humans; D010349:Patient Compliance; D016012:Poisson Distribution; D016387:Women's Health